Literature DB >> 1942241

Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.

S Bour1, F Boulerice, M A Wainberg.   

Abstract

Our results demonstrate that the formation of intracellular complexes between the envelope glycoprotein precursor gp160 of human immunodeficiency virus type 1 and CD4 is a major event, leading to the disappearance of CD4 at the cell surface of infected U937 cells. Using both productively and defectively infected clones of U937 cells, we assessed the effect of CD4-gp160 intracellular association on the maturation of both proteins. Pulse-chase labeling followed by sequential immunoprecipitation was used to analyze the processing of both free and associated CD4 and gp160, and the results showed that the trimming, proteolytic cleavage, and degradation of gp160 were completely abrogated after intracellular binding to CD4. Similarly, the maturation process which normally transforms 80% of CD4 to a partially endoglycosidase H-resistant species was also impaired subsequent to the formation of these complexes. A comparison of gp160 maturation either in free form or as a CD4 complex revealed that neither inefficient transport nor degradation of gp160 can account for the observed blockage of CD4 maturation. Moreover, this impairment was independent of gp120 and gp41, since a defective clone of human immunodeficiency virus type 1-infected cells, unable to cleave gp160, showed binding of CD4 and inhibition of CD4 transport and maturation with the same efficiency as occurred in productively infected cells. Expression of gp160 is thus necessary and sufficient to cause CD4 receptor down-modulation for both productively and defectively infected cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942241      PMCID: PMC250675     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.

Authors:  B Crise; L Buonocore; J K Rose
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

Review 2.  Protein degradation in the endoplasmic reticulum.

Authors:  R D Klausner; R Sitia
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

3.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  The organization of the envelope projections on the surface of HIV.

Authors:  M Ozel; G Pauli; H R Gelderblom
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120.

Authors:  H Geyer; C Holschbach; G Hunsmann; J Schneider
Journal:  J Biol Chem       Date:  1988-08-25       Impact factor: 5.157

6.  Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.

Authors:  J M McCune; L B Rabin; M B Feinberg; M Lieberman; J C Kosek; G R Reyes; I L Weissman
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

7.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

8.  Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.

Authors:  M Stevenson; C Meier; A M Mann; N Chapman; A Wasiak
Journal:  Cell       Date:  1988-05-06       Impact factor: 66.850

9.  Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.

Authors:  P Salmon; R Olivier; Y Riviere; E Brisson; J C Gluckman; M P Kieny; L Montagnier; D Klatzmann
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein.

Authors:  R W Doms; A Ruusala; C Machamer; J Helenius; A Helenius; J K Rose
Journal:  J Cell Biol       Date:  1988-07       Impact factor: 10.539

View more
  34 in total

1.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

Review 2.  HIV-1 Vpu - an ion channel in search of a job.

Authors:  Klaus Strebel
Journal:  Biochim Biophys Acta       Date:  2013-07-03

Review 3.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

Review 4.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

5.  Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates.

Authors:  A Otteken; P L Earl; B Moss
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.

Authors:  D J Volsky; M Simm; M Shahabuddin; G Li; W Chao; M J Potash
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.

Authors:  Nina Thakkar; Vanessa Pirrone; Shendra Passic; Wei Zhu; Vladyslav Kholodovych; William Welsh; Robert F Rando; Mohamed E Labib; Brian Wigdahl; Fred C Krebs
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

8.  Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.

Authors:  U Schubert; S Bour; R L Willey; K Strebel
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.

Authors:  S Anderson; D C Shugars; R Swanstrom; J V Garcia
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.

Authors:  M J Vincent; N U Raja; M A Jabbar
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.